82 related articles for article (PubMed ID: 2990589)
1. The Epstein-Barr virus (EBV): a Rosetta Stone for understanding the role of viruses in immunopathological disorders and in human carcinogenesis.
de-Thé G
Biomed Pharmacother; 1985; 39(2):49-51. PubMed ID: 2990589
[TBL] [Abstract][Full Text] [Related]
2. Virus-associated lymphomas, leukaemias and immunodeficiencies in Africa.
de-Thé G
IARC Sci Publ; 1984; (63):727-44. PubMed ID: 6100286
[TBL] [Abstract][Full Text] [Related]
3. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
4. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
Paramita DK; Fachiroh J; Artama WT; van Benthem E; Haryana SM; Middeldorp JM
J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
[TBL] [Abstract][Full Text] [Related]
5. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
[TBL] [Abstract][Full Text] [Related]
6. [Biology of the Epstein-Barr virus].
Morand P; Seigneurin JM
Ann Biol Clin (Paris); 1989; 47(7):421-7. PubMed ID: 2554764
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus and Burkitt's lymphoma worldwide: the causal relationship revisited.
de-Thé G
IARC Sci Publ; 1985; (60):165-76. PubMed ID: 2998987
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
Liu MT; Yeh CY
Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma.
Paramita DK; Fachiroh J; Haryana SM; Middeldorp JM
J Clin Virol; 2008 Aug; 42(4):343-52. PubMed ID: 18455473
[TBL] [Abstract][Full Text] [Related]
10. Human lymphotropic viruses associated with lymphoid malignancy: Epstein-Barr and HTLV-1.
Ambinder RF
Hematol Oncol Clin North Am; 1990 Aug; 4(4):821-33. PubMed ID: 2172203
[TBL] [Abstract][Full Text] [Related]
11. The biology and serology of Epstein-Barr virus (EBV) infections.
Klein G
Bull Cancer; 1976; 63(3):399-410. PubMed ID: 187269
[TBL] [Abstract][Full Text] [Related]
12. Immunologic markers for Epstein-Barr virus in the control of nasopharyngeal carcinoma and Burkitt lymphoma.
Levine PH
Cancer Detect Prev Suppl; 1987; 1():217-23. PubMed ID: 2826001
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus and oncogenesis: from latent genes to tumours.
Young LS; Murray PG
Oncogene; 2003 Aug; 22(33):5108-21. PubMed ID: 12910248
[TBL] [Abstract][Full Text] [Related]
14. [Significance of cell-free Epstein-Barr virus DNA in monitoring prognosis of nasopharyngeal carcinoma].
Cao SM; Min HQ; Gao JS; Hong MH; Xiao XB; Zhang CQ; Liu XD; Zhang AL; Guo X
Ai Zheng; 2003 Mar; 22(3):302-6. PubMed ID: 12654192
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus associated diseases: an update.
Pathmanathan R
Malays J Pathol; 1993 Dec; 15(2):105-13. PubMed ID: 8065170
[TBL] [Abstract][Full Text] [Related]
16. [Epstein-Barr virus infections. New pathogenic and clinical aspects].
Wilmes E; Wolf H
Laryngorhinootologie; 1989 Jan; 68(1):36-43. PubMed ID: 2536874
[TBL] [Abstract][Full Text] [Related]
17. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
Levine PH; Pearson GR; Armstrong M; Bengali Z; Berenberg J; Easton J; Goepfert H; Henle G; Henle W; Heffner D; Huang A; Hyams VJ; Lanier A; Neel HB; Pilch B; Pointek N; Taylor W; Terebelo H; Weiland L
Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus--associated diseases in humans.
Kawa K
Int J Hematol; 2000 Feb; 71(2):108-17. PubMed ID: 10745621
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus and epithelial cells: implications for the otolaryngologist.
Clark DR; Young LS; Proops DW
J Otolaryngol; 1988 Feb; 17(1):1-3. PubMed ID: 2830415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
